Passive Biotech

iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

$21.84

+0.8% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Genomics Immunology and Healthcare ETF IDNA
Fund Size
$176 Million
Dividend
1.0%
Fees
0.47%
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.3%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.2%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.3%
Fees
0.03%
View 1287 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $40.1 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.69 %
Beta Indicates the relationship between the price performance of a share and the market. 0.7276
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 111.93
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -20.64
Profitable Companies 42
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 40.28
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 4.35
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 9.13
Enterprise Value to Revenue Enterprise value divided by revenue 184.23
Total Debt to Enterprise Value Total debt divided by enterprise value 0.11
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.3622
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -2120.31%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -16.42%
Return on Assets Indicates a company's profitability in relation to its total assets. -10.85%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -14.63%

Industries

Healthcare 78.2%
Other 5.5%
N/A 16.4%

Market cap

Micro Cap 2%
Small Cap 21%
Mid Cap 23%
Large Cap 50%
Mega Cap 5%

55 Investments

P/E-Ratio
Total Investment
Weight
BlackRock Funds III logo

BlackRock Funds III

P/E-Ratio
n/a
Total Investment
$26.1 Million
Weight
21.2%
Sarepta Therapeutics Inc logo

SRPT - Manufacturing

Sarepta Therapeutics Inc

P/E-Ratio
-21.8
Total Investment
$6.58 Million
Weight
5.3%
Moderna Inc logo

MRNA - Manufacturing

Moderna Inc

P/E-Ratio
-8.7
Total Investment
$5.91 Million
Weight
4.8%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
875.3
Total Investment
$5.45 Million
Weight
4.4%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
25.1
Total Investment
$5.4 Million
Weight
4.4%
REVOLUTION Medicines Inc logo

RVMD - Manufacturing

REVOLUTION Medicines Inc

P/E-Ratio
-14.1
Total Investment
$5.29 Million
Weight
4.3%
GSK PLC logo

GSK - Manufacturing

GSK PLC

P/E-Ratio
13.5
Total Investment
$5.09 Million
Weight
4.1%
Incyte Corp logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp

P/E-Ratio
20.6
Total Investment
$5.08 Million
Weight
4.1%
Sanofi SA logo

SNY - Health Technology

Sanofi SA

P/E-Ratio
19.7
Total Investment
$5.04 Million
Weight
4.1%
Takeda Pharmaceutical Co Ltd logo

TAK - Manufacturing

Takeda Pharmaceutical Co Ltd

P/E-Ratio
32.3
Total Investment
$4.88 Million
Weight
4.0%
Roche Holding AG logo

RHHVF - Health Technology

Roche Holding AG

P/E-Ratio
12.9
Total Investment
$4.85 Million
Weight
3.9%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
15.1
Total Investment
$4.71 Million
Weight
3.8%
Exelixis Inc logo

EXEL - Professional, Scientific, and Technical Services

Exelixis Inc

P/E-Ratio
33.1
Total Investment
$4.64 Million
Weight
3.8%
BioNTech SE logo

BNTX - Manufacturing

BioNTech SE

P/E-Ratio
20.1
Total Investment
$4.47 Million
Weight
3.6%
Genmab A/S logo

GMAB - Professional, Scientific, and Technical Services

Genmab A/S

P/E-Ratio
0.0
Total Investment
$4.12 Million
Weight
3.3%
BeiGene Ltd logo

BGNE - Manufacturing

BeiGene Ltd

P/E-Ratio
-15.8
Total Investment
$3.66 Million
Weight
3.0%
Arcellx Inc logo

ACLX

Arcellx Inc

P/E-Ratio
0.0
Total Investment
$3.52 Million
Weight
2.9%
SpringWorks Therapeutics Inc logo

SWTX - Manufacturing

SpringWorks Therapeutics Inc

P/E-Ratio
0.0
Total Investment
$3.45 Million
Weight
2.8%
Twist Bioscience Corp logo

TWST - Professional, Scientific, and Technical Services

Twist Bioscience Corp

P/E-Ratio
-9.2
Total Investment
$2.89 Million
Weight
2.3%
Beam Therapeutics Inc logo

BEAM - Manufacturing

Beam Therapeutics Inc

P/E-Ratio
-16.8
Total Investment
$2.7 Million
Weight
2.2%
Dynavax Technologies Corp logo

DVAX - Manufacturing

Dynavax Technologies Corp

P/E-Ratio
-243.1
Total Investment
$2.67 Million
Weight
2.2%
Ginkgo Bioworks Holdings Inc logo

SRNGU - Manufacturing

Ginkgo Bioworks Holdings Inc

P/E-Ratio
0.0
Total Investment
$2.58 Million
Weight
2.1%
Iovance Biotherapeutics Inc logo

IOVA - Manufacturing

Iovance Biotherapeutics Inc

P/E-Ratio
0.0
Total Investment
$2.47 Million
Weight
2.0%
Ligand Pharmaceuticals Inc logo

LGND - Manufacturing

Ligand Pharmaceuticals Inc

P/E-Ratio
27.6
Total Investment
$1.94 Million
Weight
1.6%
Ono Pharmaceutical Co Ltd logo

Ono Pharmaceutical Co Ltd

P/E-Ratio
n/a
Total Investment
$1.76 Million
Weight
1.4%